Literature DB >> 18444927

Reversal of cardiac cirrhosis following orthotopic heart transplantation.

M G Crespo-Leiro1, O Robles, M J Paniagua, R Marzoa, C Naya, X Flores, F Suárez, M Gómez, Z Grille, J J Cuenca, A Castro-Beiras, F Arnal.   

Abstract

Irreversible hepatic cirrhosis greatly increases the risks attending heart transplantation (HT), and is accordingly considered to be an absolute contraindication for HT unless combined heart and liver transplantation can be performed. It is now recognized that hepatic cirrhosis can undergo regression if the source of insult is removed, but no cases of post-HT regression of cirrhosis of cardiac origin have hitherto been reported. Here we report a case of cardiac cirrhosis that underwent complete regression following orthotopic HT, and we discuss the implications of this case.

Entities:  

Mesh:

Year:  2008        PMID: 18444927     DOI: 10.1111/j.1600-6143.2008.02227.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

2.  Pulmonary arterial hypertension: an unusual cause of portal hypertension.

Authors:  Enric Reverter; Susana Seijo; Jaime Bosch
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

Review 3.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

4.  The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation.

Authors:  Christine Y Louie; Michael X Pham; Tami J Daugherty; Neeraja Kambham; John P T Higgins
Journal:  Mod Pathol       Date:  2015-03-20       Impact factor: 7.842

5.  Liver function monitoring in Fontan-procedure patients: audit of current practice across South Wales.

Authors:  Elliott J Carande; Gergely Szantho
Journal:  Br J Cardiol       Date:  2021-06-02

6.  Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.

Authors:  Kathleen E Simpson; Amir Esmaeeli; Geetika Khanna; Francis White; Yumirle Turnmelle; Pirooz Eghtesady; Umar Boston; Charles E Canter
Journal:  J Heart Lung Transplant       Date:  2013-10-25       Impact factor: 10.247

7.  Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation.

Authors:  M Isabel Fiel; Hai-Shan Wu; Kishore Iyer; Gonzalo Rodriguez-Laiz; Thomas D Schiano
Journal:  J Gastrointest Surg       Date:  2009-05-06       Impact factor: 3.452

Review 8.  Histopathological evaluation of liver fibrosis and cirrhosis regression.

Authors:  Regina C Lo; Haeryoung Kim
Journal:  Clin Mol Hepatol       Date:  2017-12-20

Review 9.  Liver abnormalities in pulmonary arterial hypertension.

Authors:  Nils P Nickel; Gian M Galura; Marc J Zuckerman; M Nawar Hakim; Haider Alkhateeb; Debabrata Mukherjee; Eric D Austin; Gustavo A Heresi
Journal:  Pulm Circ       Date:  2021-10-21       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.